BHCM
EVH icon

Brevan Howard Capital Management’s Evolent Health EVH Stock Holding History

Brevan Howard Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-28,594
Closed -$242K – 1942
2025
Q3 		$242K Sell
28,594
-48,713
-63% -$473K ﹤0.01% 1676
2025
Q2 		$870K Buy
+77,307
New +$710K 0.01% 1133
2025
Q1 		– Sell
-54,465
Closed -$613K – 1251
2024
Q4 		$613K Buy
+54,465
New +$957K ﹤0.01% 560

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brevan Howard Capital Management's EVH Position: Q4 2025 in Review

Brevan Howard Capital Management sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 28,594 shares — an estimated $242K sold.

Brevan Howard Capital Management first reported a position in EVH in Q4 2024 and held it in 3 quarters. The position peaked at $870K in Q2 2025. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • Brevan Howard Capital Management reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
  • Brevan Howard Capital Management sold 28,594 Evolent Health shares in Q4 2025, an estimated $242K.
  • Brevan Howard Capital Management first reported a position in Evolent Health in Q4 2024 and held it in 3 quarters.
  • Brevan Howard Capital Management's Evolent Health position peaked at $870K in Q2 2025.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.